Genko Oyama,
CO ASO PROF
Department:
MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone:
(352) 273-5550
Business Email:
genko@ufl.edu
Publications
Academic Articles
2024
A proof of concept: digital diary using 24-hour monitoring using wearable device for patients with Parkinson’s disease in nursing homes.
Frontiers in neurology.
15
[DOI] 10.3389/fneur.2024.1356042.
[PMID] 38660090.
2024
Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson’s disease patients.
Scientific data.
11(1)
[DOI] 10.1038/s41597-024-03909-6.
[PMID] 39406833.
2024
Digital detection of Alzheimer’s disease using smiles and conversations with a chatbot.
Scientific reports.
14(1)
[DOI] 10.1038/s41598-024-77220-0.
[PMID] 39487204.
2024
Editorial: Remote monitoring technologies in neurodegenerative movement disorders.
Frontiers in neurology.
15
[DOI] 10.3389/fneur.2024.1421454.
[PMID] 39055318.
2024
Efficacy and Safety of Elobixibat in Parkinson’s Disease with Chronic Constipation: CONST-PD Study.
Movement disorders clinical practice.
11(4):352-362
[DOI] 10.1002/mdc3.13972.
[PMID] 38264844.
2024
Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson’s disease.
Journal of the neurological sciences.
457
[DOI] 10.1016/j.jns.2024.122883.
[PMID] 38246127.
2024
Human induced pluripotent stem cell-derived dopaminergic neurons release alpha-synuclein through neuronal activity.
Neuroscience research.
[DOI] 10.1016/j.neures.2024.11.007.
[PMID] 39617169.
2024
Real-world local field potential recordings in patients with deep brain stimulation for Parkinson’s disease.
Parkinsonism & related disorders.
125
[DOI] 10.1016/j.parkreldis.2024.106090.
[PMID] 38538474.
2024
Subthalamic nucleus local field potential stability in patients with Parkinson’s disease.
Neurobiology of disease.
199
[DOI] 10.1016/j.nbd.2024.106589.
[PMID] 38969232.
2023
A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease.
Frontiers in neuroscience.
17
[DOI] 10.3389/fnins.2023.1202027.
[PMID] 37502682.
2023
A Narrative Review of Current Status and Future Perspective of Telemedicine for Parkinson’s Disease, Dementia, and Intractable Neurological Diseases in Japan.
Juntendo Iji zasshi = Juntendo medical journal.
69(1):14-20
[DOI] 10.14789/jmj.JMJ22-0031-R.
[PMID] 38854844.
2023
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan.
Scientific reports.
13(1)
[DOI] 10.1038/s41598-023-29382-6.
[PMID] 36918552.
2023
Deep brain stimulation in posterior subthalamic area for Holmes tremor: Case reports with review of the literature.
Frontiers in neurology.
14
[DOI] 10.3389/fneur.2023.1139477.
[PMID] 37034086.
2023
Long-read sequencing resolves a complex structural variant in PRKN Parkinson’s disease.
medRxiv : the preprint server for health sciences.
[DOI] 10.1101/2023.08.14.23293948.
[PMID] 37790330.
2023
Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson’s Disease.
Movement disorders : official journal of the Movement Disorder Society.
38(12):2249-2257
[DOI] 10.1002/mds.29610.
[PMID] 37926948.
2023
Role of the subthalamic nucleus in perceiving and estimating the passage of time.
Frontiers in aging neuroscience.
15
[DOI] 10.3389/fnagi.2023.1090052.
[PMID] 36936495.
2023
Three-dimensional gait analysis of the effect of directional steering on gait in patients with Parkinson’s disease.
Parkinsonism & related disorders.
114
[DOI] 10.1016/j.parkreldis.2023.105770.
[PMID] 37499354.
2022
Can AI make people happy? The effect of AI-based chatbot on smile and speech in Parkinson’s disease.
Parkinsonism & related disorders.
99:43-46
[DOI] 10.1016/j.parkreldis.2022.04.018.
[PMID] 35596975.
2022
Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose.
Journal of movement disorders.
15(3):290-292
[DOI] 10.14802/jmd.22021.
[PMID] 35880379.
2022
Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey.
Journal of movement disorders.
15(1):58-61
[DOI] 10.14802/jmd.21096.
[PMID] 34937160.
2022
Deep Brain Stimulation for a Patient with Familial Parkinson’s Disease Harboring CHCHD2 p.T61I.
Movement disorders clinical practice.
9(3):407-409
[DOI] 10.1002/mdc3.13428.
[PMID] 35402650.
2022
Genotype-phenotype correlation of Parkinson’s disease with PRKN variants.
Neurobiology of aging.
114:117-128
[DOI] 10.1016/j.neurobiolaging.2021.12.014.
[PMID] 35123805.
2022
Impaired virtual space-tilting perception in Parkinson’s disease with Pisa syndrome.
Parkinsonism & related disorders.
104:30-34
[DOI] 10.1016/j.parkreldis.2022.09.002.
[PMID] 36208613.
2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD).
BMJ open.
12(2)
[DOI] 10.1136/bmjopen-2021-054129.
[PMID] 35149566.
2022
Prevalence and characteristics of dry eye disease in Parkinson’s disease: a systematic review and meta-analysis.
Scientific reports.
12(1)
[DOI] 10.1038/s41598-022-22037-y.
[PMID] 36319814.
2022
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury.
Frontiers in human neuroscience.
16
[DOI] 10.3389/fnhum.2022.813387.
[PMID] 35308605.
2022
Short-Term Motor Outcomes in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study.
Parkinson's disease.
2022
[DOI] 10.1155/2022/8448638.
[PMID] 35992727.
2022
Subthalamic deep brain stimulation in Parkinson’s disease with SNCA mutations: Based on the follow-up to 10Â years.
Brain and behavior.
12(2)
[DOI] 10.1002/brb3.2503.
[PMID] 35040589.
2022
White matter microstructures in Parkinson’s disease with and without impulse control behaviors.
Annals of clinical and translational neurology.
9(3):253-263
[DOI] 10.1002/acn3.51504.
[PMID] 35137566.
2021
Clinical manifestations of Parkinson’s disease harboring VPS35 retromer complex component p.D620N with long-term follow-up.
Parkinsonism & related disorders.
84:139-143
[DOI] 10.1016/j.parkreldis.2021.02.014.
[PMID] 33611076.
2021
Closed-loop programming using external responses for deep brain stimulation in Parkinson’s disease.
Parkinsonism & related disorders.
84:47-51
[DOI] 10.1016/j.parkreldis.2021.01.023.
[PMID] 33556765.
2021
Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson’s Disease: A Systematic Review.
Movement disorders : official journal of the Movement Disorder Society.
36(8):1759-1771
[DOI] 10.1002/mds.28595.
[PMID] 33899262.
2021
New modalities and directions for dystonia care.
Journal of neural transmission (Vienna, Austria : 1996).
128(4):559-565
[DOI] 10.1007/s00702-020-02278-9.
[PMID] 33389184.
2021
Varicella-zoster virus encephalitis resembling herpes simplex virus encephalitis.
BMJ case reports.
14(12)
[DOI] 10.1136/bcr-2021-247602.
[PMID] 34972787.
2021
White matter alterations in Parkinson’s disease with levodopa-induced dyskinesia.
Parkinsonism & related disorders.
90:8-14
[DOI] 10.1016/j.parkreldis.2021.07.021.
[PMID] 34325387.
2021
White matter and nigral alterations in multiple system atrophy-parkinsonian type.
NPJ Parkinson's disease.
7(1)
[DOI] 10.1038/s41531-021-00236-0.
[PMID] 34716335.
2020
[Telemedicine in Neurological Diseases].
Brain and nerve = Shinkei kenkyu no shinpo.
72(10):1057-1060
[DOI] 10.11477/mf.1416201648.
[PMID] 33051392.
2020
A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia.
Tremor and other hyperkinetic movements (New York, N.Y.).
10
[DOI] 10.5334/tohm.58.
[PMID] 32775020.
2020
An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East.
Frontiers in human neuroscience.
14
[DOI] 10.3389/fnhum.2020.00162.
[PMID] 32733215.
2020
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan.
Journal of human genetics.
65(9):771-781
[DOI] 10.1038/s10038-020-0772-4.
[PMID] 32398759.
2020
Evaluation of white matter microstructure in patients with Parkinson’s disease using microscopic fractional anisotropy.
Neuroradiology.
62(2):197-203
[DOI] 10.1007/s00234-019-02301-1.
[PMID] 31680195.
2020
Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules.
Movement disorders clinical practice.
7(2):240-242
[DOI] 10.1002/mdc3.12894.
[PMID] 32071951.
2020
Holomedicine: Proof of the Concept of Interactive Three-Dimensional Telemedicine.
Movement disorders : official journal of the Movement Disorder Society.
35(10):1719-1720
[DOI] 10.1002/mds.28249.
[PMID] 32926470.
2020
Neurocognitive and psychiatric disorders-related axonal degeneration in Parkinson’s disease.
Journal of neuroscience research.
98(5):936-949
[DOI] 10.1002/jnr.24584.
[PMID] 32026517.
2020
Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report.
Journal of the neurological sciences.
411
[DOI] 10.1016/j.jns.2020.116710.
[PMID] 32044685.
2020
Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations.
NPJ Parkinson's disease.
6(1)
[DOI] 10.1038/s41531-020-00137-8.
[PMID] 33298969.
2020
Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure.
Journal of movement disorders.
13(1):57-61
[DOI] 10.14802/jmd.19051.
[PMID] 31986869.
2020
The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson’s disease.
PloS one.
15(10)
[DOI] 10.1371/journal.pone.0240491.
[PMID] 33057432.
2020
Young age and severity of motor function are risk factors for psychosis after subthalamic nucleus deep brain stimulation for Parkinson’s disease.
Psychiatry and clinical neurosciences.
74(5):328-329
[DOI] 10.1111/pcn.12991.
[PMID] 32057166.
2019
A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson’s Disease.
Parkinson's disease.
2019
[DOI] 10.1155/2019/9403295.
[PMID] 30723541.
2019
Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).
Parkinson's disease.
2019
[DOI] 10.1155/2019/7104071.
[PMID] 31467660.
2019
Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI.
Neuroradiology.
61(12):1387-1395
[DOI] 10.1007/s00234-019-02279-w.
[PMID] 31401723.
2019
Free-Water Imaging in White and Gray Matter in Parkinson’s Disease.
Cells.
8(8)
[DOI] 10.3390/cells8080839.
[PMID] 31387313.
2019
Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia.
PloS one.
14(8)
[DOI] 10.1371/journal.pone.0219758.
[PMID] 31393884.
2019
Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson’s disease.
Scandinavian journal of gastroenterology.
54(6):787-792
[DOI] 10.1080/00365521.2019.1619830.
[PMID] 31125265.
2018
A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: A case report.
Journal of the neurological sciences.
384:126-128
[DOI] 10.1016/j.jns.2017.11.029.
[PMID] 29249370.
2018
Association between abnormal nocturnal blood pressure profile and dementia in Parkinson’s disease.
Parkinsonism & related disorders.
46:24-29
[DOI] 10.1016/j.parkreldis.2017.10.014.
[PMID] 29126762.
2018
Cerebral microbleeds and blood pressure abnormalities in Parkinson’s disease.
eNeurologicalSci.
10:5-11
[DOI] 10.1016/j.ensci.2017.12.002.
[PMID] 29736422.
2018
Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson’s disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
Journal of the neurological sciences.
385:134-139
[DOI] 10.1016/j.jns.2017.12.030.
[PMID] 29406893.
2018
Effect of subthalamic nucleus deep brain stimulation on visual scanning.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology.
129(11):2421-2432
[DOI] 10.1016/j.clinph.2018.08.003.
[PMID] 30292079.
2018
GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease.
Journal of neurology.
265(8):1860-1870
[DOI] 10.1007/s00415-018-8930-8.
[PMID] 29948246.
2018
Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease.
Tremor and other hyperkinetic movements (New York, N.Y.).
8
[DOI] 10.7916/D86H5R1H.
[PMID] 29423337.
2018
Pilot Study of a Device to Induce the Hanger Reflex in Patients with Cervical Dystonia.
Neurologia medico-chirurgica.
58(5):206-211
[DOI] 10.2176/nmc.oa.2017-0111.
[PMID] 29607887.
2018
Randomized, double-blind, multicenter trial of hydrogen water for Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society.
33(9):1505-1507
[DOI] 10.1002/mds.27472.
[PMID] 30207619.
2018
The presence of cerebral microbleeds is associated with cognitive impairment in Parkinson’s disease.
Journal of the neurological sciences.
393:39-44
[DOI] 10.1016/j.jns.2018.08.009.
[PMID] 30103062.
2018
Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation.
BMJ case reports.
2018
[DOI] 10.1136/bcr-2017-223722.
[PMID] 29909386.
2018
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease.
Cells.
8(1)
[DOI] 10.3390/cells8010014.
[PMID] 30597973.
2017
[Deep Brain Stimulation for Parkinson Disease:Mechanisms and New Technology].
No shinkei geka. Neurological surgery.
45(1):5-14
[DOI] 10.11477/mf.1436203439.
[PMID] 28100856.
2017
A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson’s disease.
Parkinsonism & related disorders.
34:66-68
[DOI] 10.1016/j.parkreldis.2016.10.018.
[PMID] 28341223.
2017
Deep brain stimulation for Parkinson’s disease.
Nihon rinsho. Japanese journal of clinical medicine.
75(1):83-88
[PMID] 30566299.
2017
Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics.
BMC neurology.
17(1)
[DOI] 10.1186/s12883-017-0817-2.
[PMID] 28219346.
2017
Management of impulse control disorders with deep brain stimulation: A double-edged sword.
Journal of the neurological sciences.
374:63-68
[DOI] 10.1016/j.jns.2017.01.019.
[PMID] 28126343.
2017
Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
PloS one.
12(9)
[DOI] 10.1371/journal.pone.0183711.
[PMID] 28902876.
2016
A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics.
BMC neurology.
16
[DOI] 10.1186/s12883-016-0589-0.
[PMID] 27176725.
2016
Atypical parkinsonism caused by Pro105Leu mutation of prion protein: A broad clinical spectrum.
Neurology. Genetics.
2(1)
[DOI] 10.1212/NXG.0000000000000048.
[PMID] 27066585.
2016
Current Topics in Deep Brain Stimulation for Parkinson Disease.
Neurologia medico-chirurgica.
56(10):613-625
[PMID] 27349658.
2015
Alleviation of myoclonus after bilateral pallidal deep brain stimulation for Lance-Adams syndrome.
Journal of neurology.
262(6):1581-3
[DOI] 10.1007/s00415-015-7748-x.
[PMID] 25929661.
2015
High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.
Neurobiology of aging.
36(5):2004.e9-2004.e15
[DOI] 10.1016/j.neurobiolaging.2015.01.020.
[PMID] 25744623.
2015
Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson’s disease: a quantitative study.
Brain stimulation.
8(1):64-75
[DOI] 10.1016/j.brs.2014.10.011.
[PMID] 25440578.
2014
Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation.
Tremor and other hyperkinetic movements (New York, N.Y.).
4
[DOI] 10.7916/D8KS6PPR.
[PMID] 24932426.
2014
Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues.
Tremor and other hyperkinetic movements (New York, N.Y.).
4
[DOI] 10.7916/D8542KQ5.
[PMID] 25120941.
2014
Deep brain stimulation may improve quality of life in people with Parkinson’s disease without affecting caregiver burden.
Neuromodulation : journal of the International Neuromodulation Society.
17(2):126-32
[PMID] 24024760.
2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson’s disease.
Neurobiology of aging.
35(11):2656.e17-2656.e23
[DOI] 10.1016/j.neurobiolaging.2014.05.025.
[PMID] 24973808.
2014
Posterior subthalamic area deep brain stimulation for fragile X-associated tremor/ataxia syndrome.
Neuromodulation : journal of the International Neuromodulation Society.
17(8):721-3
[DOI] 10.1111/ner.12150.
[PMID] 24528808.
2014
Rescue GPi-DBS for a Stroke-associated Hemiballism in a Patient with STN-DBS.
Tremor and other hyperkinetic movements (New York, N.Y.).
4
[DOI] 10.7916/D8XP72WF.
[PMID] 24587970.
2014
Subthalamic deep brain stimulation for a Parkinson’s disease patient with duplication of SNCA.
Neuromodulation : journal of the International Neuromodulation Society.
17(1):102-3
[DOI] 10.1111/ner.12034.
[PMID] 23441980.
2013
[Mechanism of action for deep brain stimulation and electrical neuro-network modulation (ENM)].
Rinsho shinkeigaku = Clinical neurology.
53(9):691-4
[PMID] 24097315.
2013
[Update on deep brain stimulation for movement disorders].
Rinsho shinkeigaku = Clinical neurology.
53(11):911-4
[PMID] 24291831.
2013
A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.
Tremor and other hyperkinetic movements (New York, N.Y.).
3
[DOI] 10.7916/D86W98SW.
[PMID] 24255805.
2013
Differential and better response to deep brain stimulation of chorea compared to dystonia in Huntington’s disease.
Stereotactic and functional neurosurgery.
91(2):129-33
[DOI] 10.1159/000341070.
[PMID] 23343665.
2013
Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson’s disease: results from an open-label study.
Drug research.
63(12):639-43
[DOI] 10.1055/s-0033-1351257.
[PMID] 23884661.
2013
Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: JAPAN.
Neurology. Clinical practice.
3(6):477-478
[DOI] 10.1212/01.CPJ.0000437021.22294.25.
[PMID] 30123690.
2013
Taking a better history for behavioral issues pre- and post-deep brain stimulation: issues missed by standardized scales.
Neuromodulation : journal of the International Neuromodulation Society.
16(1):35-9; discussion 39
[DOI] 10.1111/j.1525-1403.2012.00477.x.
[PMID] 22748071.
2013
Validity of single tract microelectrode recording in subthalamic nucleus stimulation.
Neurologia medico-chirurgica.
53(11):821-7
[PMID] 24140767.
2012
Addiction-like manifestations and Parkinson’s disease: a large single center 9-year experience.
The International journal of neuroscience.
122(3):145-53
[DOI] 10.3109/00207454.2011.633722.
[PMID] 22023411.
2012
Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson’s disease?
The Journal of neuropsychiatry and clinical neurosciences.
24(3):326-30
[DOI] 10.1176/appi.neuropsych.11090210.
[PMID] 23037646.
2012
Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.
PloS one.
7(1)
[DOI] 10.1371/journal.pone.0029768.
[PMID] 22295068.
2012
GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson’s disease.
Parkinsonism & related disorders.
18(7):814-8
[DOI] 10.1016/j.parkreldis.2012.03.022.
[PMID] 22525365.
2012
Low-Frequency Deep Brain Stimulation for Dystonia: Lower is Not Always Better.
Tremor and other hyperkinetic movements (New York, N.Y.).
2
[DOI] 10.7916/D85X27PH.
[PMID] 23450104.
2012
Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system.
Neuromodulation : journal of the International Neuromodulation Society.
15(3):246-50; discussion 250
[DOI] 10.1111/j.1525-1403.2012.00437.x.
[PMID] 22376158.
2011
Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson’s disease.
Parkinsonism & related disorders.
17(3):189-93
[DOI] 10.1016/j.parkreldis.2010.12.004.
[PMID] 21276745.
2011
Delayed clinical improvement after deep brain stimulation-related subdural hematoma. Report of 4 cases.
Journal of neurosurgery.
115(2):289-94
[DOI] 10.3171/2011.3.JNS101424.
[PMID] 21476805.
2011
Effect of Deep Brain Stimulation on Parkinson’s Nonmotor Symptoms following Unilateral DBS: A Pilot Study.
Parkinson's disease.
2011
[DOI] 10.4061/2011/507416.
[PMID] 22220288.
2011
Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms.
Journal of neurology.
258(11):2069-74
[DOI] 10.1007/s00415-011-6075-0.
[PMID] 21553081.
2011
Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome.
Tremor and other hyperkinetic movements (New York, N.Y.).
1
[DOI] 10.7916/D8XG9PWK.
[PMID] 23440654.
2011
Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism.
The Clinical neuropsychologist.
25(1):141-59
[DOI] 10.1080/13854046.2010.532812.
[PMID] 21253963.
2011
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy.
Parkinsonism & related disorders.
17(6):451-5
[DOI] 10.1016/j.parkreldis.2011.03.009.
[PMID] 21482169.
2011
Steady or not following thalamic deep brain stimulation for essential tremor.
Journal of neurology.
258(9):1643-8
[DOI] 10.1007/s00415-011-5986-0.
[PMID] 21442464.
2011
The distal partial trisomy 1q syndrome and dystonic tremor.
Parkinsonism & related disorders.
17(2):128-9
[DOI] 10.1016/j.parkreldis.2010.10.004.
[PMID] 21044857.
2011
The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment.
Parkinson's disease.
2011
[DOI] 10.4061/2011/290195.
[PMID] 21808724.
2011
Unilateral deep brain stimulation surgery in Parkinson’s disease improves ipsilateral symptoms regardless of laterality.
Parkinsonism & related disorders.
17(10):745-8
[DOI] 10.1016/j.parkreldis.2011.07.010.
[PMID] 21856205.
2011
Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease.
The neurologist.
17(5):282-5
[DOI] 10.1097/NRL.0b013e318217367b.
[PMID] 21881473.
2010
Differential response of dystonia and parkinsonism following globus pallidus internus deep brain stimulation in X-linked dystonia-parkinsonism (Lubag).
Stereotactic and functional neurosurgery.
88(5):329-33
[DOI] 10.1159/000319961.
[PMID] 20714213.
2010
Impaired in vivo dopamine release in parkin knockout mice.
Brain research.
1352:214-22
[DOI] 10.1016/j.brainres.2010.06.065.
[PMID] 20620130.
2009
Mechanism and treatment of dropped head syndrome associated with parkinsonism.
Parkinsonism & related disorders.
15(3):181-6
[DOI] 10.1016/j.parkreldis.2008.04.040.
[PMID] 18573677.
2009
Subsecond reward-related dopamine release in the mouse dorsal striatum.
Neuroscience research.
63(4):267-72
[PMID] 19367786.
2007
Fabrication, characterization, and application of boron-doped diamond microelectrodes for in vivo dopamine detection.
Analytical chemistry.
79(22):8608-15
[PMID] 17918970.
2005
[Familial amyotrophic lateral sclerosis with rapid progression].
No to shinkei = Brain and nerve.
57(11):1003-6
[PMID] 16363640.
Contact Details
Phones:
- Business:
- (352) 273-5550
Emails:
- Business:
- genko@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100236
GAINESVILLE FL 32610 - Business Street:
-
PO Box 100236
GAINESVILLE FL 32610